Jim Cramer broke down his guidelines for smart investing and how investors should approach the market. » Read More
Jim Cramer explains important role cash plays in a portfolio, and how he outperformed the market as a money manager. » Read More
Jim Cramer reveals his No. 1 rule to buying a stock, and the different tactics that go into investing and trading. » Read More
Jim Cramer shares his experience of getting burned and the importance of discipline. » Read More
A defiant Musk took to Twitter to suggest the investors buy stock in Ford Motor instead. The Ford family controls the Detroit automaker through two classes of stock.
The "Fast Money" traders share their first moves ahead of the holiday weekend.
Some of the actively managed funds are switching from "Trump Trade" bets on financial and infrastructure stocks into retail, apparel, or biotech stocks.
Jim Cramer says oil's strained supply and demand dynamics mean investors should sell oil and buy the pipelines.
Jim Cramer reveals that the selloff has less to do with business and more to do with market perception.
The U.S. will be careful when it comes to Syria – it's North Korea that could be the real issue, Quincy Krosby told CNBC.
Infrastructure stocks fell as worries grew about economic growth and the feasibility of the Trump administration's stimulus promises.
Quarterly earnings season kicks into gear this week as reports from three big banks are set to be released on Thursday morning.
Mark 2016 as the latest 'Year of the Stock Picker' that wasn't.
Stifel upgraded Lululemon to buy from hold predicting the company will recover from its recent product mistakes.
Investors are about to see a very strong earnings season, says one strategist, who gives his take on what to expect.
A rare condition known as "backwardation" speaks to traders' anxiety over the upcoming French election.
Expectations for Wall Street are high as stocks have stalled near record highs, USA Today reports.
Shares of Tractor Supply fall after the company reported disappointing same-store sales results to start the year.
One of the most popular post-election trades just lost all its 2017 gains.
The report comes days after activist investor Jana Partners took nearly a 9% stake.
Here's the full interview of Rafferty Capital Markets’ Dick Bove on CNBC's "Squawk Box."
A popular gold miner ETF is finding it difficult to match its index after $4 billion from investors poured in amid the big bullion rally.
Neurocrine says the FDA has approved Ingrezza, the only drug for treatment of adults with tardive dyskinesia.
Here's the problem: a lot is expected to go right with bank earnings.
Get the best of CNBC in your inbox